Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial

Nat Commun. 2026 Jan 14;17(1):598. doi: 10.1038/s41467-026-68303-9.

Abstract

Oats have various positive effects on human health, but the underlying mechanisms are not fully understood. To identify oat-microbiome-host interactions contributing to metabolic improvements, we conducted two randomized controlled dietary interventions in parallel-design in individuals with metabolic syndrome, comparing a short-term, high-dose and a six-week, moderate oat intake with respective controls (DRKS00022169). Both oat diets lead to an increase in plasma ferulic acid (0.64 [0.26, 1.02], P = 0.002; 0.55 [0.21, 0.89], P = 0.003), while the high-dose oat-diet also increased dihydroferulic acid (1.23 [0.44, 2.01], P = 0.003). Here we show that microbial phenolic metabolites are driving factors for the cholesterol-lowering effect of oats, which might be of relevance since short-term, high-dose oat-diet is a suitable approach to alleviate obesity-related lipid disorders.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Avena* / chemistry
  • Avena* / metabolism
  • Cholesterol* / blood
  • Coumaric Acids / blood
  • Female
  • Gastrointestinal Microbiome
  • Humans
  • Male
  • Metabolic Syndrome* / blood
  • Metabolic Syndrome* / diet therapy
  • Metabolic Syndrome* / metabolism
  • Metabolic Syndrome* / microbiology
  • Middle Aged
  • Phenols* / metabolism

Substances

  • Coumaric Acids
  • ferulic acid
  • Phenols
  • Cholesterol